Editor - BiopharmaJournal.com

449 POSTS 0 COMMENTS

Wall Street is my passion and I love pursuing it but with a pen ! After my Master's in Journalism, I joined Bio Pharma Journal as a freelance writer and was soon promoted to an associate editor position.

Adagio Therapeutics Inc. (NASDAQ: ADGI) Announces That ADG20 Produced A Neutralizing...

Kate Hudson - January 21, 2022 0

Investors Focus on Top Metaverse Plays as New Year Gets in...

Kate Hudson - January 21, 2022 0

Mersana Therapeutics Inc. (NASDAQ: MRSN) Advancing Upri As A Foundation For...

Kate Hudson - January 21, 2022 0

$Curis Inc. (NASDAQ: CRIS) Reports Positive Dose Escalation And Expansion Results Of CA-4948 in Refractory/Relapsed AML/MDS$

Curis Inc. (NASDAQ: CRIS) Reports Positive Dose Escalation And Expansion Results...

Kate Hudson - January 21, 2022 0

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) Report Positive GENEr8-1 Study Of...

Kate Hudson - January 20, 2022 0

Kintara Therapeutics Inc. (NASDAQ: KTRA) Announce Multi-Year Grant for to Dr....

Kate Hudson - January 19, 2022 0

Why the EV Pullback Could be a Once-in-a-Lifetime Opportunity for Investors...

Kate Hudson - January 18, 2022 0

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Announces Enrolment Of First Subject...

Kate Hudson - January 18, 2022 0

Immix Biopharma Inc. (NASDAQ: IMMX) Release Study Showing That IMX-110 Can...

Kate Hudson - January 17, 2022 0

Ocugen Inc. (NASDAQ: OCGN) and Bharat Biotech Announce Study Results Showing...

Kate Hudson - January 17, 2022 0

12 3...45 Page 1 of 45

Adagio Therapeutics Inc. (NASDAQ: ADGI) Announces That ADG20 Produced A Neutralizing...

Kate Hudson - January 21, 2022 0

Adagio Therapeutics Inc. (NASDAQ: ADGI) has summarised recent findings that were published in three different publications showing its flagship monoclonal antibody (mAb), ADG20, had...